Novo’s CEO is in no rush to find his replacement
The next head of Novo Nordisk’s European business is likely to come from outside the company ranks, but CEO Lars Fruergaard is in no rush to find the executive to take up his old position. Increased uncertainty in the US means the group is preparing for a dip in sales for the first time in decades.
BY STEFAN SINGH KAILAY
Lars Fruergaard Jørgensen is busy handling the consequences of his appointment as CEO and successor to Lars Rebien Sørensen – a job he began just a month ago.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
